Zebra Capital Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $261K | Sell |
|
|||||
|
2022
Q2 | $279K | Buy |
|
|||||
|
2022
Q1 | $353K | Sell |
|
|||||
|
2021
Q4 | $392K | Sell |
|
|||||
|
2021
Q3 | $628K | Sell |
|
|||||
|
2021
Q2 | $912K | Sell |
|
|||||
|
2021
Q1 | $1.01M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $201K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $362K | Buy |
|
|||||
|
2017
Q4 | $287K | Sell |
|
|||||
|
2017
Q3 | $363K | Buy |
|
|||||
|
2017
Q2 | $234K | Buy |
|